RECRUITING

Lifestyle Patterns and Glycemic Control

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of the proposed study is to evaluate the feasibility and initial efficacy of stabilizing lifestyle behaviors to improve glucose control and body composition in patients with pre-diabetes. The investigator proposes that following stable lifestyle behaviors will improve patients' glucose control, body composition, and liver fat. The results from this study has the potential to impact clinical practice and patient care.

Official Title

Lifestyle Patterns and Glycemic Control

Quick Facts

Study Start:2022-01-19
Study Completion:2025-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05224986

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pre-diabetic kg/m2 (hemoglobin A1c 5.7-6.9%)
  2. * 25 years or older
  3. * BMI between 25-39.9 kg/m2
  4. * Sleep duration ≥6 hours a night assessed with wrist actigraphy (for 14 nights)
  5. * Variable bedtime, SD≥45 minutes.
  1. * Chronic Kidney Disease (GFR\<60)
  2. * Uncontrolled hypertension (≥160/100 mmHg)
  3. * Obstructive Sleep Apnea
  4. * Psychiatric or neurological disorder
  5. * Prevalent cardiovascular disease
  6. * Dyslipidemia (triglycerides≥200 mg/dL)
  7. * Medications that affect insulin sensitivity, glucose concentrations, and body weight
  8. * Non-day or rotating shift workers
  9. * Travel across time zones
  10. * Active participation in weight loss program or within past 3 months
  11. * Current or past alcohol/drug abuse

Contacts and Locations

Study Contact

Marie-Pierre St-Onge
CONTACT
212-851-5578
ms2554@cumc.columbia.edu
Lena Navarro
CONTACT
347-963-8845
lrn2116@cumc.columbia.edu

Principal Investigator

Marie-Pierre St-Onge
PRINCIPAL_INVESTIGATOR
Columbia University
Blandine Laferrere
PRINCIPAL_INVESTIGATOR
Columbia University

Study Locations (Sites)

Columbia University Irving Medical Center
New York, New York, 10032
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Marie-Pierre St-Onge, PRINCIPAL_INVESTIGATOR, Columbia University
  • Blandine Laferrere, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-19
Study Completion Date2025-06-01

Study Record Updates

Study Start Date2022-01-19
Study Completion Date2025-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Pre-diabetes